domingo, 29 de marzo de 2020

Digital therapy for chronic insomnia gains FDA signoff - STAT

Digital therapy for chronic insomnia gains FDA signoff - STAT

Daily Recap

STAT Plus: Digital therapy for chronic insomnia gains FDA signoff

By CASEY ROSS


ADOBE
Called Somryst, it is the first digital treatment approved for chronic insomnia, which affects more than 30 million adults in the U.S.

No hay comentarios:

Publicar un comentario